A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T‐CELL LYMPHOMAS: PRELIMINARY RESULTS OF A PHASE II TRIAL. (12th June 2019) - William, B.M.; Abbasi, A.; Huang, Y.; Larbi, R.; Giali, R.; Yang, L.; Brammer, J.; Grantier, C.; Hoffman, C.; Ayyappan, S.; Baiocchi, R.; Epperla, N.; et al.